THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
Adult glioblastoma
Paediatric high-grade glioma
EU initiative for understanding cancer
Magnetic resonance imaging
Standard of care
Immuno-oncology
Tumour treating fields
Oslo University Hospital is affiliated with the Faculty of Medicine of the University of Oslo and is one of the largest medical research institutions in Europe. Every year more than 700 patients are treated for brain tumours at the institution ranging across all treatment modalities. The hospital offers surgery with intraoperative MRI combined with advanced cognitive neuromonitoring, molecular diagnostics, advanced neuro-oncology in combinations with an early phase trial unit. Treatment is given as close to the patient as possible through a close collaboration with the regional hospitals and primary health care service.
What is OUS’ main role?
Which work packages is OUS involved in?
OUS contributes primarily to work package 5 and supports work packages 2, 7 and 8.
See our dedicated page for more details on the GLIOMATCH work plan.
Who will represent OUS?